GemPharmatech (SH:688046) Xin Lang Cai Jing·2025-09-15 03:47Group 1 - Jiangsu Jicui Yaokang Biotechnology Co., Ltd. was established on December 29, 2017, and went public on April 25, 2022, with a current market capitalization of 7.934 billion yuan [1] - The company's main business involves the research, production, sales, and related technical services of laboratory mouse models, with revenue composition as follows: commercial mouse model sales 55.36%, functional efficacy 23.46%, custom breeding 11.32%, model creation 7.06%, and agency import/export and others 2.70% [1] Group 2 - Noan Fund's Noan Pioneer Mixed A (320003) is among the top ten circulating shareholders of Yaokang Biotechnology, having reduced its holdings by 1.0721 million shares in the second quarter, now holding 5.3339 million shares, which is 1.3% of circulating shares [2] - The fund has achieved a year-to-date return of 29.91% and a one-year return of 60.29%, ranking 2678 out of 8246 and 2184 out of 8054 respectively [2] Group 3 - The fund manager of Noan Pioneer Mixed A is Yang Gu, who has a cumulative tenure of 19 years and 211 days, with the fund's total asset size at 5.133 billion yuan [3] - During Yang Gu's tenure, the best fund return was 1033.17%, while the worst was 3.03% [3]